Table 1 Key findings in the clinical area of Diabetes Mellitus Type I and II
Lead Author/Year | Country | Study design | Sample size | Duration | Age group (in Years) | Intervention | Delivery frequency | Measures of outcome | Results – control (C) versus intervention (I) |
|---|---|---|---|---|---|---|---|---|---|
Ananth Samoth Shetty/2011 [34] | India | RCT | 215 | 12 months | 30–65 | SMS | Once in 3 days | Adherence to management prescription | Hb1Ac level |
I: 30.8 to 55.1Â % | |||||||||
C: 31.8Â % to 48.5Â %. | |||||||||
V. L. Franklin/ 2006 [13] | Scotland | RCT | 90 | 12 months | 8–18 | SMS, emergency hotline | Daily SMS | Self-efficacy, adherence to treatment | I and C using conventional therapy:10.3 ± 1.7 vs. 10.1 ± 1.7 % |
I with intensive insulin therapy and Sweet Talk: 9.2 ± 2.2 %, 95 % CI −1.9, −0.5, P < 0.001 | |||||||||
Self-reported adherence: conventional therapy 70.4 ± 20.0, conventional therapy plus Sweet Talk 77.2 ± 16.1, 95 % CI +0.4, +17.4, P = 0.042 | |||||||||
M. Vervloet/2012 [38] | Netherland | RCT | 104 | 6 months | 18–65 | SMS reminder | SMS only incase patient didn’t open the medication dispenser | Adherence to oral hypoglycaemic agent | Doses within predefined time windows, within a 1-h window |
I: 50Â % | |||||||||
C:39Â % | |||||||||
within a 4-h window | |||||||||
I: 81Â % | |||||||||
C: 70Â % | |||||||||
Mandana Goodarzi/2012 [16] | Iran | RCT | 81 | 3Â months | 30+ | SMS | 4 SMS weekly | Improving laboratory test levels and Knowledge, Attitude, Practice (KAP) and Self Efficacy (SE) of patients | HbA1C level |
C: 7.83 to 7.48Â % | |||||||||
I: 7.91 to 7.02Â %. | |||||||||
LDL level | |||||||||
C: 99.13Â mg/dl to 98.95Â mg/dl | |||||||||
I: 97.88gm/dl to 87.93gm/dl. | |||||||||
Triglyceride | |||||||||
C: 173.4Â mg/dl to 169.08Â mg/dl | |||||||||
I: 179.72 gm/dl to 160.16gm/dl. | |||||||||
Knowledge improved 7.97 to 10.83Â %, practice 3.72 to 4.93Â %, and SE 15.34 to 17.02Â % in I I group. |